A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis

Trial Profile

A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Apr 2016

At a glance

  • Drugs Mesalazine (Primary)
  • Indications Ulcerative colitis
  • Focus Pharmacokinetics
  • Sponsors Shire
  • Most Recent Events

    • 05 Apr 2013 New source identified and integrated (United Kingdom Clinical Research Network; 12598).
    • 12 Jan 2013 Planned number of patients changed from 30 to 64 as reported by European Clinical Trials Database.
    • 12 Jan 2013 New source identified and integrated (EudraCT2011-000164-10: European Clinical Trials Database).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top